Table 1 Patient characteristics based on primary chemotherapy received
Parameters | Cisplatin (n = 66) | Cetuximab (n = 55) |
|---|---|---|
Sex | ||
Male | 51 | 39 |
Female | 15 | 16 |
Age | ||
> 60 | 18 | 33 |
≤ 60 | 48 | 22 |
Mean ± SD (Overall 60.09 ± 10.28) | 56.80 ± 9.10 | 60.04 ± 10.30 |
HPV/p16 | ||
Positive | 34 | 21 |
Negative | 9 | 7 |
Not available | 23 | 27 |
Primary | ||
Oropharynx | 55 | 45 |
Hypopharynx/Larynx | 5 | 7 |
Oral Cavity | 5 | 2 |
Other | 1 | 1 |
Elevated baseline creatinine (> 1.3 mg/dL) | ||
Yes | 14 | 13 |
No | 43 | 38 |
Not Available | 9 | 4 |
Smoking | ||
Smoker | 44 | 32 |
Light (< 10 Pack-Years) | 10 | 4 |
Heavy (≥ 10 Pack-Years) | 26 | 25 |
Unknown Pack-Years | 8 | 3 |
Non-Smoker | 21 | 21 |
Not Available | 1 | 2 |
Comorbidities | ||
Yes (≥ 2 Conditions) | 48 | 35 |
No (< 2 Conditions) | 16 | 16 |
Not Available | 2 | 4 |
T Staging | ||
T1 | 6 | 11 |
T2 | 26 | 20 |
T3 | 20 | 14 |
T4 | 12 | 9 |
Tx | 2 | 1 |
N staging | ||
N0 | 3 | 7 |
N1 | 8 | 8 |
N2 | 46 | 36 |
N3 | 7 | 2 |
Nx | 2 | 2 |
M staging | ||
M0 | 60 | 51 |
M1 | 0 | 0 |
Mx | 6 | 4 |